The levels of interleukin-6, soluble interleukin-6 and vascular endothelial growth factor receptors during delivery at term, threatened preterm labor, and in preeclampsia

Shcherbakov V.I., Pozdnyakov I.M., Shirinskaya A.V., Volkov M.V.

1Research Institute of Experimental and Clinical Medicine, Novosibirsk 630117, Timakova str. 2, Russia 2Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk 630091, Krasny pr. 52, Russia 3Novosibirsk City Clinical Perinatal Center, Novosibirsk 630089, Adriena Lezhena str. 32, Russia 4Clinical Maternity Hospital Six, Novosibirsk 630048, Vertkovskaya str. 5, Russia
Objective. To study of the serum levels of interleukin-6 (IL-6), soluble IL-6 and vascular endothelial growth factor (VEGF) receptors in women during delivery at term, threatened preterm labor, and in preeclampsia.
Subjects and methods. A total of 85 pregnant women who were divided into 4 groups were examined. Group 1 included 35 women with physiological delivery; Group 2 consisted of 11 with threatened preterm labor; Group 3 comprised 23 with preeclampsia; Group 4 (a control group) included 16 with physiological pregnancy. A solid-phase enzyme-linked immunoabsorbent assay was used to determine the serum levels of IL-6, soluble IL-6 and VEGF receptors.
Results. The level of IL-6 was shown to increase dramatically in women with physiological delivery while the level in those with threatened preterm labor was approximately the same as that in the controls. The content of soluble IL-6 receptor was opposite to that of IL-6. The level of soluble VEGF receptor 1 reduced in threatened preterm labor and increases in physiological delivery and preeclampsia.

Keywords

preeclampsia
preterm labor
interleukin-6
soluble receptors

Supplementary Materials

  1. Fig.1 Interleukine 6 level in the control group, in case of threatened preterm labor, in case of physiologic labor and in case of preeclampsia
  2. Fig.2 Soluble receptor of interleukine 6 level in the control group, in case of threatened preterm labor, in case of physiologic labor and in case of preeclampsia
  3. Fig.3 Soluble receptor 1 of epidermal growth factor in the control group, in case of threatened preterm labor, in case of physiologic labor and in case of preeclampsia
  4. Fig. 4. Potential model explaining myometrium contraction degree in case of physiologic (term) labor and threated preterm labor.

References

1. Skripchenko Yu.P., Baranov II, Tokova Z.Z. Statistics of premature birth. Problemy reproduktsii. 2014; 20 (4): 11-4. (in Russian)

2. Wakabayashi A., Sawada K., Nakayama M., Toda A., Kimoto A., Mabuchi S. et al. Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation. Mol. Hum. Reprod. 2013; 9(11):718-26.

3. Shcherbakov V.I., Ryabichenko T.I., Skosyreva G.A., Trunov A.N. Mechanisms of intrauterine programming of obesity in children. The Rossiyskiy vestnik perinatologii i pediatrii. 2013; 58 (5): 8-14. (in Russian)

4. Fowden A.L., Giussani D.A., Forhead A.J. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21: 29-37.

5. Makarov O.V., Volkova E.V., Lysyuk E.Yu., Kopylova Yu.V., Dzhokhadze L.S. Role of angiogenic growth factors in the pathogenesis of preeclampsia and placental insufficiency. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2014; (12): 64-70. (in Russian)

6. Gomez-Lopez N., Laresgoiti-Servitje E., Olson D.M., Estrada-Gutiérrez G., Vadillo-Ortega F. The role of chemokine in term and premature rupture of the fetal membranes: a review. Biol. Reprod. 2010;82(5): 809-14.

7. Srikhajon K., Shynlova O., Preechapornprasert A., Chanrachakul B., Lye S. A new role for monocytes in modulating myometrial inflammation during human labor. Biol. Reprod. 2014; 91(1): 10-21.

8. Thomson A.J., Telfer J.F., Young A., Campbell S., Stewart C.J., Cameron I.T. et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is s an inflammatory process. Hum. Reprod. 1999; 14(1): 229-36.

9. Щербаков В.И. Плацента и ее роль в патогенезе преэклампсии. Новосибирск: СГУПС; 2012. 200с. [Shcherbakov V.I. Placenta and its role in the pathogenesis of preeclampsia. Novosibirsk: SGUPS; 2012. 200p. (in Russian)

10. Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T. et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 2004; 187(2): 388-402.

11. Pennington K.A., Schlitt J.M., Jackson D.L., Schulz L.C., Schust D.J. Preeclampsia: multiple approaches for a multifactorial disease. Dis. Model. Mech. 2012; 5(1): 9-18.

12. Petersen A.M.W., Pedersen B.K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005; 98(4): 1154-62.

13. Pedersen B.K., Febbrao M.A. Muscule as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 2008; 88(4): 1379-406.

14. Rajagopal S.P., Hutchinson J.L., Dorward D.A., Rossi A.G., Norman J.E. Crosstalk between monocytes and myometrial smooth muscle in culture generates synergistic pro-inflammatory cytokine production and enhances myocyte contraction, with effects opposed progesterone. Mol. Hum. Reprod. 2015; 21(8): 672-86.

15. Febbraio M.A., Pedersen B.K. Muscle derived interleikin-6: mechanisms for activation and possible biological roles. FASEB J. 2002; 16(11): 1335-47.

16. Prins J.R., Gomez-Lopez N., Robertson S.A. Interleukin-6 in pregnancy and gestational disorders. J. Reprod. Immunol. 2012; 25(1-2): 1-14.

17. McLoughlin R.M., Hurst S.M., Nowell M.A., Harris D.A., Horiuchi S., Morgan L.W. et al. Differential regulation of neutrophils-activating chemokines by IL-6 and ist soluble receptor isoforms. J. Immunol. 2004; 172(9): 5676-83.

18. Rana S., Karumanchi S.A., Levine R.J., Venkatesha S., Rauh-Hain J.A., Tamez H., Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007; 50(1):137-42.

19. Cindrova-Davies T., Yung H.W., Johns J., Spasic-Boskovic O., Korolchuk S., Jauniaux E. et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am. J. Pathol. 2007; 171(4): 1168-79.

20. Tal R., Segars J.H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum. Reprod. 2014; 20(2): 194-216.

21. Stranghen J.K., Kumar P., Mistra V.K. The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery. J. Matern. Fetal Neonatal Med. 2012; 25(10): 1679-83.

22. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Bloоd. 1996; 97(8): 3336-43.

Received 20.06.2016

Accepted 02.09.2016

About the Authors

Shcherbakov Vladimir Ivanovich, doctor of medical sciences, research fellow of the Immunology Laboratory, Research Institute of Experimental and Clinical Medicine.
630117, Russia, Novosibirsk, Timakova str. 2. Tel.: +79137122188. E-mail: Shcherbakov_VI@mail.ru
Pozdnyakov Ivan Mikhailovich, Doctor of Medical Sciences, Professor of the Department of Obstetrics and Gynecology of Novosibirsk State Medical University,
Ministry of Health of Russia; Chief Physician of Novosibirsk City Clinical Perinatal Center. 630091, Russia, Novosibirsk, Krasny pr. 52
Shirinskaya Anna Vladimirovna, obstetrician-gynecologist of Novosibirsk City Clinical Perinatal Center, women’s consultation No. 2.
630089, Russia, Novosibirsk, Adriena Lezhena str. 32. Tel.: +79232341007. E-mail: anncharm2004@mail.ru
Volkov Mikhail Valentinovich, obstetrician-gynecologist, Clinical Maternity Hospital Six, women’s consultation.
630048, Russia, Novosibirsk, Vertkovskaya str. 5. Tel.: +79133918932. E-mail: Michaelis67@mail.ru

For citations: Shcherbakov V.I., Pozdnyakov I.M., Shirinskaya A.V., Volkov M.V. The levels of interleukin-6, soluble interleukin-6 and vascular endothelial growth factor receptors during delivery at term, threatened preterm labor, and in preeclampsia. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (3): 50-4. (in Russian)
http://dx.doi.org/10.18565/aig.2017.3.50-4

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.